Kineret 100 mg/0.67 ml solution for injection in pre-filled syringe. clinical trials
5 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
ANA4CKD - Randomized multicenter double-blind controlled trial comparing anakinra to prednisone for gout flare in patients with chronic kidney disease stage 4-5 or kidney transplantation
This study is looking at two treatments for painful gout attacks in people with kidney disease or a kidney transplant: anakinra and prednisone. Researchers want to see which one works better and causes fewer side effects by measuring pain levels and other health changes.
For: Men and women over 18 years of age with renal failure renal failure stages 3b/4/5 · renal transplantation or dialysis and an untreated gout attackFrance - AuthorisedTherapeutic exploratory (Phase II)
Efficacy and safety of anakinra in non-COVID-19 related ARDS. ESKA study.
This study is looking at a medicine called Kineret to treat a serious lung condition called ARDS in adults. We want to see if Kineret can help patients breathe on their own sooner, without needing a ventilator.
For: Acute respiratory distress syndrome (ARDS)Italy - AuthorisedTherapeutic use (Phase IV)
Biomarker-guided treatment-and-stop-strategy for recombinant IL-1receptor antagonist (anakinra) in patients with systemic Juvenile Idiopathic Arthritis
This study looks at how many injections of a medicine called anakinra (Kineret) children with systemic JIA need to stop their disease symptoms. It also checks if they stay well after stopping the medicine.
For: autoimmune disorders · joint disorders synonym: Still's disease · systemic JIANetherlands - AuthorisedTherapeutic confirmatory (Phase III)
ANAKINRA IN THE TREATMENT OF PEDIATRIC ACUTE MYOCARDITIS. ANAPEM
This study is looking at a new treatment called Kineret for children with a serious heart condition called myocarditis. It wants to see if Kineret helps their heart recover faster than a dummy treatment, by checking how well the heart pumps blood after 3 days.
For: PEDIATRIC ACUTE MYOCARDITISFrance - AuthorisedPhase I and Phase II (Integrated)- Other
IL-1β blockade to prevent Immunothrombosis in recipients of a Pancreatic Organ (ILIPO)
This study is looking at new ways to prevent problems after a pancreas transplant in people with diabetes. It will test if a medicine called Kineret can help stop serious infections and rejections, aiming for better health after the transplant.
For: diabetic patients pancreatic transplantFrance